Marshall Gerstein Named 2015 “Biotechnology Law Firm of the Year – USA” by Lawyer Monthly

August 19, 2015

For the third year in a row, Marshall, Gerstein & Borun LLP was named "Biotechnology Law Firm of the Year – USA" by the Lawyer Monthly Legal Awards 2015. The Lawyer Monthly Legal Awards recognize achievements of lawyers, law firms and associated legal professionals whose knowledge and expertise continue to influence the wider profession. Winning firms were selected for their demonstration of professional achievement and excellence in their jurisdiction and sector of practice.

The Firm’s Biotechnology Group includes lawyers and patent agents who have broad experience in a variety of biotechnology disciplines, including: DNA, RNA, vaccine, protein, and antibody therapeutics and diagnostics; cell-based and viral therapeutics; drug and gene therapy delivery vehicles; plant biotechnology; industrial technology and research platforms; nanotechnology and interdisciplinary inventions. The Firm’s professionals are skilled at providing patent counseling relating to the interface between patents, clinical product development, FDA regulations and regulatory exclusivity.

Marshall Gerstein is experienced in traditional, chemical-based pharmaceuticals, formulations, and delivery technologies. The Firm has procured, enforced and/or defended patents for biotech companies relating to a number of billion-dollar biologic or pharmaceutical products and has handled key patents for clients covering more than a dozen different commercially marketed pharmaceutical products and numerous clinical trial candidates.

Lawyer Monthly is a global website and print publication providing news, analysis and features on the latest legal news across key practices areas, jurisdictions and sectors from around the world in both established and emerging markets.